Our Netcells team is proud to announce that we have released a second unit of umbilical cord blood belonging to a three-year-old Netcells baby born with cerebral palsy.
Expectant parents are faced with a number of decisions before the birth of a baby, among them whether to collect the baby’s umbilical cord blood at birth.
The merger of local leaders in stem cell banking and genetic testing consolidates their position in the African biotechnology industry.
A newborn screening test is done in collaboration with North-West University and includes tests relevant to the South African population.
Next Biosciences will work closely with CHOC to ensure that any unutilised funds from procedural fees donated by obstetricians will be directed to CHOC, as the Netcells ‘Families of Hope’ programme’s goals are closely aligned to theirs: Keeping more than hope alive.
Winner of first South African Global Impact Competition presents an innovative concept to address HIV/AIDS.
Children with cerebral palsy can now be treated with sibling cord blood therapy.
Cord blood stem cells are currently being used to treat 80+ diseases, including many blood cancers like leukaemia and lymphoma.
Second autologous transplant for aplastic anaemia successful
Umbilical cord serum contains essential tear components, and umbilical cord serum eyedrops are effective and safe for treating severe dry eye syndrome.
